News: NICE boost for Inditherm medical products
Innovative medical products from Rotherham-based Inditherm have been given final approval from The National Institute for Health and Clinical Excellence (NICE). A move that is expected to lead for further business in the NHS.
NICE are recognised as being a world leader in setting standards for high quality healthcare and are the most prolific producer of clinical guidelines in the world. They have issued guidance that supports the use of Inditherm patient warming systems for patients undergoing operations which carry risk of inadvertent hypothermia.
Inditherm products use low voltage carbon polymer technology to provide heat and unlike other forms of heating, there are no hot spots. In addition, the system ensures that every surgical patient can be warmed at the same running cost as a light-bulb.
After rigorous evaluation of the clinical evidence, NICE concluded that the effectiveness of the Inditherm patient warming mattress is similar to that of forced air warming in maintaining patient core body temperature above 36°C and that the Inditherm system may have practical advantages.
NICE also estimate that the cost saving when the Inditherm patient warming system replaces forced air warming is estimated to be £9800 annually per operating theatre.
Professor Carole Longson, director of the NICE Centre for Health Technology Evaluation, said: "We are very pleased to publish guidance today advising that the Inditherm patient warming mattress should be considered for use in patients at risk of inadvertent hypothermia.
"The evidence examined indicates that as well as benefiting patients by reducing a range of serious complications associated with inadvertent hypothermia, it also benefits the NHS by saving money."
Nick Bettles, chief executive of Inditherm added: "We are delighted that NICE has recognised the value of our patient warming mattress both in terms of its effectiveness in maintaining patient core body temperature and the cost savings it offers.
"This could save the NHS in England alone well over £15m per annum if forced air warming was replaced by Inditherm's mattress for eligible procedures in most of the 3,030 operating theatres.
"I am confident that this positive recommendation will see an increasing interest in our product and its more consistent use across NHS operating theatres, with additional income starting to flow as it gets embraced into the NHS budgeting process."
Earlier this month, the AIM-listed Manvers firm received another boost to their medical business after they were awarded a contract by the UK NHS Supply Chain to include their products in the NHS online catalogue.
Inditherm website
Images: inditherm.co.uk
NICE are recognised as being a world leader in setting standards for high quality healthcare and are the most prolific producer of clinical guidelines in the world. They have issued guidance that supports the use of Inditherm patient warming systems for patients undergoing operations which carry risk of inadvertent hypothermia.
Inditherm products use low voltage carbon polymer technology to provide heat and unlike other forms of heating, there are no hot spots. In addition, the system ensures that every surgical patient can be warmed at the same running cost as a light-bulb.
After rigorous evaluation of the clinical evidence, NICE concluded that the effectiveness of the Inditherm patient warming mattress is similar to that of forced air warming in maintaining patient core body temperature above 36°C and that the Inditherm system may have practical advantages.
NICE also estimate that the cost saving when the Inditherm patient warming system replaces forced air warming is estimated to be £9800 annually per operating theatre.
Professor Carole Longson, director of the NICE Centre for Health Technology Evaluation, said: "We are very pleased to publish guidance today advising that the Inditherm patient warming mattress should be considered for use in patients at risk of inadvertent hypothermia.
"The evidence examined indicates that as well as benefiting patients by reducing a range of serious complications associated with inadvertent hypothermia, it also benefits the NHS by saving money."
Nick Bettles, chief executive of Inditherm added: "We are delighted that NICE has recognised the value of our patient warming mattress both in terms of its effectiveness in maintaining patient core body temperature and the cost savings it offers.
"This could save the NHS in England alone well over £15m per annum if forced air warming was replaced by Inditherm's mattress for eligible procedures in most of the 3,030 operating theatres.
"I am confident that this positive recommendation will see an increasing interest in our product and its more consistent use across NHS operating theatres, with additional income starting to flow as it gets embraced into the NHS budgeting process."
Earlier this month, the AIM-listed Manvers firm received another boost to their medical business after they were awarded a contract by the UK NHS Supply Chain to include their products in the NHS online catalogue.
Inditherm website
Images: inditherm.co.uk
0 comments:
Post a Comment